Affiliation:
1. CHU Clermont-Ferrand, Department of Rheumatology, Hôpital Gabriel Montpied, Clermont-Ferrand, France
Abstract
Abstract
The number of elderly people with chronic inflammatory rheumatic diseases is increasing. This heterogeneous and comorbid population is at particular risk of cardiovascular, neoplastic, infectious and iatrogenic complications. The development of biotherapies has paved the way for innovative therapeutic strategies, which are associated with toxicities. In this review, we have focused on the scientific and therapeutic changes impacting the management of elderly patients affected by RA, SpA or PsA. A multidimensional health assessment resulting in an integrated therapeutic strategy was identified as a major research direction for improving the management of elderly patients.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference170 articles.
1. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet,2015
2. Inflamm-aging. An evolutionary perspective on immunosenescence;Franceschi;Ann N Y Acad Sci,2000
3. Immunosenescence: what does it mean to health outcomes in older adults?;McElhaney;Curr Opin Immunol,2009
4. Principles of drug therapy for the elderly patient;Bressler;Mayo Clin Proc,2003
5. Bias and causal associations in observational research;Grimes;Lancet,2002
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献